摘要
目的探讨舒利迭在中重度慢性阻塞性肺病治疗中的依从性和疗效方法将80例中重度COPD患者随机平均分为两组,对照组40例采用常规治疗措施。观察组在此基础上同时吸入舒利迭治疗。治疗3月后,观查并比较两组患者的肺功能和临床症状以及依从性评估。结果试验后观察组肺功能指标FEV1、FVC、FEV1/FVC%和有效率优于对照组,差异有统计学意义(P<0.05),但依从性有待提高。结论舒利迭在中重度COPD治疗中疗效良好,依从性需要提高。
Objective To explore the effect of Seretide in treatment and compliance of midrange and severe COPD. Methods Selected 80 cases with midrange and severe COPD were randomly divided into 2 groups equally. 40 patients in the control group was given regular treatment, 40 patients in the study group were treated by Seretide based on regular treatment. After 3 months treatment, the clinical effects of two groups were compared. Results The total effective rate and FEV1、FVC、FEV1/FVC% of study group is better than control group, the results was statistically significant （P0.05）,but the compliance should be improved.Conclusion Seretide in treatment of midrange and severe COPD has a good effect, but the compliance should be improved.
出处
《中国实用医药》
2013年第16期41-42,共2页
China Practical Medicine
